Evidence map›Paper›PMID 33833096›Full record

ArticleScience (New York, N.Y.)2021

Response to Comment on "Tumor-initiating cells establish an IL-33-TGF-β niche signaling loop to promote cancer progression".

Sachiko Taniguchi, Ajit Elhance, Avery Van Duzer, Sushil Kumar, Justin Leitenberger, Naoki Oshimori

Open access · bronzeAbstract readComment
PubMed Publisher
In one paragraph

Article in Science (New York, N.Y.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sachiko TaniguchiDepartment of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR 97239, USA.ORCID https://orcid.org/0000-0002-7461-8300
Ajit ElhanceDepartment of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR 97239, USA.
Avery Van DuzerDepartment of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR 97239, USA.ORCID https://orcid.org/0000-0002-9442-6955
Sushil KumarDepartment of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR 97239, USA.ORCID https://orcid.org/0000-0002-9882-0722
Justin LeitenbergerDepartment of Dermatology, Oregon Health & Science University, Portland, OR 97239, USA.ORCID https://orcid.org/0000-0001-6836-671X
Naoki OshimoriDepartment of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR 97239, USA. oshimori@ohsu.edu.ORCID https://orcid.org/0000-0002-5247-510X
Oregon Health & Science University · US

Funding

Mechanisms of cellular crosstalk in tumor-promoting niche formationR01CA245535 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI OSHIMORI, NAOKI · 2021 to 2025
$2.1M
NCI NIH HHS R01 CA245535
6 · The paper itself

Abstract

Kamphuis

Indexed as

Interleukin-33NeoplasmsHumansNeoplastic Stem CellsReceptors, IgETransforming Growth Factor betaInterleukin-33Receptors, IgETransforming Growth Factor beta

Identifiers

PMID33833096
OpenAlexW3140041170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.